Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season

Vaccination against COVID-19 and influenza provides the best defense against morbidity and mortality. Administering both vaccines concurrently may increase vaccination rates and reduce the burden on the healthcare system. This study evaluated the immunogenicity of healthcare workers in Israel who we...

Full description

Bibliographic Details
Main Authors: Stephen Moss, Menucha Jurkowicz, Ital Nemet, Nofar Atari, Limor Kliker, Bayan Abd-Elkader, Tal Gonen, Emily Toth Martin, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
COVID-19
Omicron
influenza
neutralization
hemagglutination
Online Access:https://www.mdpi.com/2076-393X/11/10/1624

Internet

https://www.mdpi.com/2076-393X/11/10/1624

Similar Items